Monthly Archives: April 2020

Ordinary People Achieving The Extraordinary: Lessons In Leadership From The Court To The C-suite
April 30, 2020

This blog was written by Josh Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC. I stood in front of 15 skeptical parents and prepared to sell them on an improbable mission. They had

Leave a comment

Running Rehab: Managing Talent In A Pandemic
April 27, 2020

This blog was written by Andrea DiMella, VP and Head of Talent at Atlas Venture, as part of the From The Trenches feature of LifeSciVC. What a difference a little time makes. When Bruce originally encouraged me to be a

Leave a comment

Reflections of an Immigrant CEO 
April 23, 2020

This blog post was written by Gerhard Koenig, CEO of Arkuda Therapeutics, as part of the From The Trenches feature of LifeSciVC. When I discussed the topic of writing about my experience as an immigrant biotech CEO with Bruce Booth,

Leave a comment

Value Creation And Destruction: Dispersion of Performance In Biotech IPOs
April 17, 2020

The biotech IPO market in 2020 remains strong, despite the volatility and COVID headwinds. We’ve seen stellar pricings and good after-market performance, with ten new offerings already this year. And the queue for companies with active S1’s on file is

Leave a comment

Booming VC-Backed Biopharma: Strong Market Despite Pandemic
April 8, 2020

Venture capital is a long investment cycle business, and never before has that been so clear as now in the face of the ongoing COVID pandemic. Even with the unprecedented public equity market volatility, venture investing into private biopharma companies

Leave a comment

Confessions Of A Planner
April 3, 2020

This blog was written by Samantha Truex, CEO of Quench Bio, as part of the From The Trenches feature of LifeSciVC.  I am a planner.  I like to plan most things well in advance; in fact, maybe too far in

Leave a comment